Company profile
NeuroOne Medical Technologies Corporation
NASDAQ: NMTC · Healthcare · Medical - Devices
#643 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
55CFH 49DQ 60GM 66SS 43
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, Piotroski F
Methodology →Revenue TTM
$10.0M
Rev growth YoY (TTM)
+50.8%
Net income (FY)
-$3.6M
Employees
18
as of 2026-08-21
Market cap
$18.7M
as of 2026-08-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$9.1M$9.1M2025
Net income-$3.6M-$3.6M2025
Operating income-$4.2M-$4.2M2025
Total assets$10.8M$10.8M2025
Liabilities$3.7M$3.7M2025
Equity$7.1M$7.1M2025
Revenue trend
FY2014 – FY2025 · USD
FY14
FY15
FY16
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NeuroOne Medical Technologies Corporation’s revenue?
NeuroOne Medical Technologies Corporation booked $9.1M in FY2025 revenue, growing 163% year over year — faster than most Healthcare companies we track, at a -39.6% net margin.
Peers · Healthcare
Curis, Inc.53DRafarma Pharmaceuticals, Inc.71BInternational Stem Cell Corporation57CHempfusion Wellness Inc.——CareView Communications, Inc.52DBioAge Labs Inc.51DNeighbors
Hennepin →Key facts
CEODavid A. Rosa
SectorHealthcare
IndustryMedical - Devices
HeadquartersEden Prairie, MN
ExchangeNASDAQ: NMTC
Employees18
IPO date2018-03-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.